Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
SYNthesis Med Chem
SYNthesis Med Chem is a provider of small molecule drug discovery services, specializing in medicinal and synthetic chemistry.
Sector
Subsector
Keywords
Location
Fundacion MEDINA
Fundacion MEDINA discovers biologically active molecules and drug candidates for industries.
Sector
Subsector
Keywords
Location
total rounds
Anima Biotech
The company is advancing mRNA Lightning, a platform for discovering selective small molecule mRNA drugs and their mechanisms of action.
Sector
Subsector
Keywords
Location
Micar Innovation (Micar21)
Micar21 uses in silico and Artificial Intelligence to provide faster drug discovery.
Sector
Subsector
Location
M&A Details1
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 19.06.2012. Their latest investor Nordic Biotech. Their latest round Venture - Series Unknown
Industrifonden
Nordic venture capital firm Industrifonden invests in early-stage technology and life science companies with international potential.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
SEB Venture Capital
SEB Venture Capital is a Fintech investor that focuses on strategic corporate venture investments in the financial technology sector.
Sector
Subsector
Location
count Of Investments
count Of Exists
SLS Venture
SLS Venture is one of the largest investment funds in Scandinavia's life science sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Nordic Biotech
Nordic Biotech Opportunity Fund is a venture capital fund that focuses on commercial services and software sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Vaekstfonden
Vaekstfonden is a state investment fund that provides capital and strategic support to diverse companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors7
Number of lead investors
Number of investors
Nordic Biotech
Nordic Biotech Opportunity Fund is a venture capital fund that focuses on commercial services and software sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Vaekstfonden
Vaekstfonden is a state investment fund that provides capital and strategic support to diverse companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Novo Holdings
Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Alex Gouliaev
Alex Haahr Gouliaev, Chief Executive Officer, holds an MSc and PhD in Chemistry from Aarhus University, Denmark. During his education, he studied at University of Southern Denmark, Odense; Dept. of Pharmacology, Odense University Hospital; Dept. of Chemistry, Aarhus University and Dept. of Medicinal Chemistry, The Royal School of Pharmacy, Copenhagen University. Alex is a co-founder of Nuevolution. He served as Executive Vice President, Chemistry and Drug Discovery from 2001 until he was appointed Chief Executive Officer in September 2005. At Nuevolution, he has been considerably involved in the establishing of Nuevolution’s platform technology for drug discovery from conception to realization. Furthermore, he has been significantly involved in Nuevolution’s partnered and internal drug discovery programs. During the period 2005-2015, he has been responsible for the negotiation and execution of 14 out of the company’s 15 agreements based on Nuevolution’s drug discovery platform. Prior to co-founding Nuevolution, he was Director of Medicinal Chemistry, member of the Management group, and a member of the Board of Directors at NeuroSearch A/S, where he worked for 6 years. During his stay at Neurosearch, he was involved in multiple CNS projects as project manager including responsibility for projects ranging from early discovery to out-sourcing and technology transfer to CRO’s for GMP production of API’s for clinical study use. During his 19 years of industry practice, he has gained experience and expertise in medicinal chemistry, pharmacology, process chemistry optimization and up-scaling of clinical candidates, technology platform development, patenting, contract drafting and negotiation, and capital raising. Alex has authored or co-authored more than 40 publications and patent applications in the fields of synthetic/medicinal chemistry, CNS pharmacology and technology development.
current job
organization founded
Alex Gouliaev